NEPAFENAC
| Brand name | NEVANAC |
|---|---|
| Active ingredient | NEPAFENAC |
| Strength | 0.1% |
| Dosage form | SUSPENSION/DROPS |
| Route | OPHTHALMIC |
| Modality | Small molecule |
| FDA approval | August 2005 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 7834059 | January 2027 | use U-1095 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.